Synektik split case study
A March 27 video, 'Podział Synektik: okazja czy pułapka dla inwestorów?', breaks down a Warsaw‑listed medical tech’s share split and planned capital raise, using it as an event‑driven trading case study with liquidity and microstructure caveats. The piece is a neat, concrete example for backtesting corporate action strategies in small‑cap, illiquid markets. (youtube.com)
Synektik’s board set the division in motion with a decision dated March 27, 2025, and shareholders unanimously approved the split at an Extraordinary General Meeting on March 19, 2026. (synektik.com.pl) The demerger will issue 8,529,129 new Syn2bio series B shares to Synektik shareholders at a 1:1 ratio (one Syn2bio share per Synektik share), and Syn2bio’s share capital will be raised to PLN 4,364,564.50 via that emission. (synektik.com.pl) The plan values the transferred asset package at PLN 163,247,529.06, implying an emission price of PLN 19.14 per Syn2bio share and meaning the spun‑off business represents roughly 7.73% of Synektik’s pre‑split value (valuation date used: June 30, 2025). (syn2bio.pl) Synektik currently has 8,529,129 shares outstanding (nominal value PLN 0.50 each) and a reported market capitalization around PLN 2.28–2.32 billion, so the division’s accounting implies an immediate mechanical reference‑price adjustment to Synektik equity of about 7.73% on the session following the record step. (synektik.com.pl) Major holders control roughly 4,188,446 shares (≈49.1% of votes) while the remaining free float is about 4,340,683 shares (≈50.9%), a concentration profile that can magnify price moves in low‑liquidity sessions after the demerger. (bankier.pl) For event‑driven backtests: treat the demerger as a corporate‑action adjustment that (a) reduces historical Synektik reference prices by 7.73% on the effective date, (b) seeds Syn2bio time‑series at PLN 19.14 per share on listing, and (c) models execution costs using Synektik’s recent average daily volume ~25–30k shares to calibrate slippage and market‑impact in order‑book simulations. (synektik.com.pl)
